News and Events Recent News Aug 8, 2019 Arrowhead Pharmaceuticals Doses First Patient in SEQUOIA Phase 2/3 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease Aug 5, 2019 Arrowhead Pharmaceuticals Reports Fiscal 2019 Third Quarter Results Jul 24, 2019 Arrowhead Pharmaceuticals to Webcast Fiscal 2019 Third Quarter Results View More » Recent Events Oct 18, 2019 Arrowhead Analyst R&D Day 2019 Sep 16, 2019 Global Summit On Cardiology & Heart Diseases Sep 5, 2019 Citi’s 14th Annual Biotech Conference View More »
Aug 8, 2019 Arrowhead Pharmaceuticals Doses First Patient in SEQUOIA Phase 2/3 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease